LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$393M |
| 2 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$317M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$260M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$207M |
| 5 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$178M |
Top Sells
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$273M |
| 2 |
iShares US Technology ETF
IYW
|
+$137M |
| 3 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$133M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$112M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$85.2M |
Sector Composition
| 1 | Technology | 6.51% |
| 2 | Financials | 3.09% |
| 3 | Healthcare | 2.97% |
| 4 | Consumer Discretionary | 2.6% |
| 5 | Industrials | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares S&P 100 ETF
OEF
$22.4B
| $64M | 0.04% |
319,228
+33,175
| +12% | +$6.66M |
|
377
SPDR S&P MidCap 400 ETF Trust
MDY
$23.8B
| $63.9M | 0.04% |
139,986
+1,079
| +0.8% | +$493K |
|
378
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.36B
| $63.9M | 0.04% |
787,705
-49,339
| -6% | -$4M |
|
379
ASML
ASML
$311B
| $63.7M | 0.04% |
108,183
+5,562
| +5% | +$3.27M |
|
380
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.5B
| $63.3M | 0.04% |
1,107,847
-32,582
| -3% | -$1.86M |
|
381
Becton Dickinson
BDX
$53.9B
| $63.1M | 0.04% |
244,078
+24,239
| +11% | +$6.27M |
|
382
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| $62.9M | 0.04% |
659,556
-5,056
| -0.8% | -$482K |
|
383
iShares Ultra Short Duration Bond Active ETF
ICSH
$6.24B
| $62.9M | 0.04% |
1,248,887
-27,334
| -2% | -$1.38M |
|
384
CSX Corp
CSX
$59.7B
| $62.8M | 0.04% |
2,041,902
+102,159
| +5% | +$3.14M |
|
385
Chubb
CB
$110B
| $62.4M | 0.04% |
299,535
+16,915
| +6% | +$3.52M |
|
386
iShares S&P Small-Cap 600 Value ETF
IJS
$6.58B
| $62.3M | 0.04% |
698,601
-54,461
| -7% | -$4.86M |
|
387
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
| $62.3M | 0.04% |
688,960
+51,902
| +8% | +$4.69M |
|
388
S&P Global
SPGI
$166B
| $62.2M | 0.04% |
170,104
+25,186
| +17% | +$9.21M |
|
389
Aflac
AFL
$57.3B
| $62M | 0.04% |
808,447
+27,660
| +4% | +$2.12M |
|
390
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.45B
| $61.8M | 0.04% |
2,906,186
+2,261,400
| +351% | +$48.1M |
|
391
Intuitive Surgical
ISRG
$161B
| $61.7M | 0.04% |
210,938
+26,164
| +14% | +$7.65M |
|
392
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $61.6M | 0.04% |
625,541
-683,417
| -52% | -$67.3M |
|
393
Target
TGT
$41.1B
| $61.4M | 0.04% |
555,617
+11,715
| +2% | +$1.29M |
|
394
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.14B
| $61.3M | 0.04% |
946,661
-10,717
| -1% | -$694K |
|
395
SPDR Portfolio High Yield Bond ETF
SPHY
$9.12B
| $61.3M | 0.04% |
2,732,257
+265,797
| +11% | +$5.96M |
|
396
Capital Group Core Equity ETF
CGUS
$7.18B
| $61.2M | 0.04% |
2,436,330
+444,540
| +22% | +$11.2M |
|
397
Capital Group Global Growth Equity ETF
CGGO
$6.99B
| $61M | 0.04% |
2,659,480
+516,118
| +24% | +$11.8M |
|
398
Enterprise Products Partners
EPD
$68.7B
| $60.6M | 0.04% |
2,213,819
+157,450
| +8% | +$4.31M |
|
399
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.44B
| $60.4M | 0.04% |
926,778
+18,318
| +2% | +$1.19M |
|
400
Vertex Pharmaceuticals
VRTX
$99.9B
| $60.4M | 0.04% |
173,737
+1,709
| +1% | +$594K |
|